Stem cell biology · BEGINNER LESSON
iPSC
Induced pluripotent stem cells are mature body cells that scientists reprogram to behave like embryonic stem cells, including self-renewal and the ability to form cells from all three germ layers. They are measured by traits such as pluripotency markers, growth capacity, morphology, and differentiation potential.
What iPSCs are
iPSCs are somatic cells, meaning ordinary body cells, that have been genetically reprogrammed into a pluripotent state. Pluripotent means they can give rise to cell types from the three germ layers: ectoderm, mesoderm, and endoderm. They also show embryonic stem cell-like morphology and strong self-renewal, meaning they can keep dividing in culture for a long time.
[1] Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease ... [2] Induced pluripotent stem cells as a next-generation biomedical ... - NIH [3] Frontier progress and translational challenges ...
How they are made and what changes inside the cell
Reprogramming is usually done by adding transcription factors, which are proteins that switch genes on and off. The classic factors are Oct4, Sox2, Klf4, and c-Myc. During reprogramming, the somatic cell’s original gene program is silenced, chromatin is remodeled, and DNA methylation is reset. DNA methylation is a chemical tag on DNA that helps control whether genes are active. A key step is reactivation of the Oct4 promoter, a DNA region that helps turn on Oct4 and stabilize pluripotency.
[1] Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease ... [2] Induced pluripotent stem cells as a next-generation biomedical ... - NIH
Why iPSCs are useful
iPSCs can be made from many cell types, including fibroblasts and blood cells, without using embryos or fertilized eggs. This makes them useful for studying disease in patient-specific cells and for generating cell types for research or possible transplantation. Their ability to expand strongly in culture also makes them a flexible cell source.
[2] Induced pluripotent stem cells as a next-generation biomedical ... - NIH [3] Frontier progress and translational challenges ... [1] Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease ...
Limitations and quality control
iPSC production is technically demanding and usually inefficient, often taking days to weeks and succeeding in only a small fraction of starting cells. Efficiency depends on factors such as donor age, cell type, and the reprogramming method. Important limitations include genomic instability, epigenetic instability, incomplete maturation of iPSC-derived cells, and the risk that undifferentiated cells can form teratomas, which are tumors made of mixed tissue types. Because of these risks, rigorous quality control such as PCR-based assays and genomic integrity checks is essential.
[1] Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease ... [2] Induced pluripotent stem cells as a next-generation biomedical ... - NIH [3] Frontier progress and translational challenges ...
SEE THE IDEA
How iPSCs are generated and evaluated
A mature body cell starts the process.
Oct4, Sox2, Klf4, and c-Myc are introduced.
Gene activity is reset; self-renewal and broad differentiation appear.
Genomic integrity and marker checks look for instability or unsafe cells.
Somatic cells are pushed into a pluripotent state, then checked for stability before use.
iPSC production links gene-resetting steps with strict testing because the cells can be unstable.
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.